Why the study?
No effective and safe vaccines are marketed against African swine fever, and removing the MGF 110 gene could improve usability and reduce side effects of naturally occurring attenuated strains.
Does deletion of the MGF 110-11L gene in the Lv17/WB/Rie1 strain reduce pathogenicity and induce immunity in pigs?
Does deletion of the MGF 110-11L gene in the Lv17/WB/Rie1 strain reduce pathogenicity and induce immunity in pigs?
Deletion of the MGF 110-11L gene from the Lv17/WB/Rie1 African Swine Fever strain reduces pathogenicity while maintaining protective capacity, serving as a step toward a live-attenuated vaccine.
Answers are grounded in this paper and cite their sources.
MGF 110-11L deletion may reduce side effects of live-attenuated ASF vaccines; leaves open safety and efficacy in target populations.
) population. To date, no effective and safe vaccines have been marketed against ASF. A starting point for vaccine development is using naturally occurring attenuated strains as a vaccine base. Here, we aimed to remove the multigene family (MGF) 110 gene of unknown function from the Lv17/WB/Rie1 genome to improve the usability of the virus as a live-attenuated vaccine, reducing unwanted side effects. The MGF 110-11L gene was deleted using the CRISPR/Cas9 method, and the safety and efficacy of the virus were tested in pigs after isolation. The vaccine candidates administered at high doses showed reduced pathogenicity compared to the parental strain and induced immunity in vaccinated animals, although several mild clinical signs were observed. Although Lv17/WB/Rie1/d110-11L cannot be used as a vaccine in its current form, it was encouraging that the undesirable side effects of Lv17/WB/Rie1 at high doses can be reduced by additional mutations without a significant reduction in its protective capacity.
No takes yet. Share an insight, caveat, or question.
Tamás et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: